England
The Rare Cancers Act 2026 – the Bill has officially become law!
We are absolutely delighted that on Thursday 5th March, the Rare Cancers Bill passed its final stage in Parliament, receiving Royal Assent and becoming the Rare Cancers Act 2026.
What the National Cancer Plan means for people affected by pancreatic cancer
On the 4th February 2026 – World Cancer Day, the Secretary of State for Health and Social Care, Wes Streeting revealed the eagerly awaited National Cancer Plan for England.
Our response to the National Cancer Plan for England
Today, Secretary of State for Health and Social Care, Wes Streeting revealed the eagerly awaited National Cancer Plan for England. Our CEO, Diana Jupp responds to its commitments and how they could turn the tide on the deadliest common cancer.
Presentations from Managing difficult conversation – Part two event
Government U-turn on publication of 10 Year Cancer Plan – our statement
Pancreatic Cancer UK's Director of Support, Research and Influencing, Anna Jewell, comments on the government's decision to scrap the 10 Year Cancer Plan for England
Introducing SABR treatment for pancreatic cancer
In Autumn 2020, Pancreatic Cancer UK helped to submit a proposal to NHS England, asking them to commission a type of radiotherapy called SABR (Stereotactic Ablative Body Radiotherapy), for people with locally advanced pancreatic cancer (LAPC). Now, SABR treatment has been commissioned for rollout in England, thanks to a group of healthcare professionals and Pancreatic Cancer UK's Research Involvement Network (RIN).
Our meeting with Jo Churchill, Cancer Minister for England
An update on our meeting with Jo Churchill, the Cancer Minister, about the impact of the pandemic on pancreatic cancer.
Our open letter to Jo Churchill, Cancer Minister for England
An open letter to Jo Churchill, the Cancer Minister, raising our concerns about how COVID-19 is impacting pancreatic cancer treatment and care.
NHS England publish National Cancer Recovery Plan for cancer services
We comment on NHS England's National Cancer Recovery Plan, which aims to restore cancer services post pandemic
NHS England announce new trial for a blood test to detect multiple cancers
We comment on NHS England's announcement about a new trial for a blood test that could help improve early diagnosis for multiple cancers, including pancreatic cancer
Spearheading the Less Survivable Cancers Taskforce
Pancreatic Cancer survival rates have not changed in 50 years. We knew that if we were to make the decision makers listen, we would have to make our voices louder.